In the current issue of JAMA Oncology, Unger et al1 provide an overview from SWOG in response to the recommendations to modernize eligibility criteria for clinical trials developed by the American Society of Oncology (ASCO), Friends of Cancer Research (Friends), and the National Cancer Institute (NCI) to support less restrictive eligibility criteria to broaden participation in clinical trials.2-6
Mishkin G, Arnaldez F, Ivy SP. Drivers of Clinical Trial Participation—Demographics, Disparities, and Eligibility Criteria. JAMA Oncol. 2019;5(3):305–306. doi:10.1001/jamaoncol.2018.5949
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: